Stock listing
Frankfurt:2TG STERIS plc (Ireland) Aktie
German listing (Frankfurt) of STERIS plc (Ireland) · home listing NYSE:STE
Follow STERIS plc (Ireland) into a list and get an email when it puts out news.
Share price · FWB:2TG
€233.40 EUR +2.80 (+1.2%)
Close on Nov 20, 2026
- Day range
- €221.80 – €233.40 EURNov 20, 2026
- Market cap
- €22.76B EURAt the close on Nov 20, 2026 · price × 97.50M shares outstanding
- 52-week range
- €163.81 – €233.40 EURLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- €2,005 EURMedian day 0 shares · 45 days with no trades · last 3 months, Aug 20, 2026 – Nov 6, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NYSE:STE · Home | $255.76 USD | -3.81 (-1.5%) | 823,416 | $257.05 | $259.35 | $254.99 | $259.57 | Close on Nov 20, 2026 |
| Frankfurt:2TG | €233.40 EUR | +2.80 (+1.2%) | — | €221.80 | €233.40 | €221.80 | €230.60 | Close on Nov 20, 2026 |
| B3:S1TE34 | 52.14 BRL | 0.00 (0.0%) | — | 52.14 | 52.14 | 52.14 | 52.14 | Close on Nov 19, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 6, 2026 · FWB:2TG · EUR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| €225.23 | +13.67 | +6.5% | €218.08 | €225.80 | €217.93 | 5 | |
| €211.56 | +15.91 | +8.1% | €211.56 | €211.56 | €211.56 | 56 | |
| €195.64 | -2.964 | -1.5% | €195.64 | €195.64 | €195.64 | 56 | |
| €198.61 | -7.156 | -3.5% | €198.61 | €198.61 | €198.61 | 0 | |
| €205.76 | +4.932 | +2.5% | €196.14 | €205.85 | €194.95 | 0 | |
| €200.83 | +1.384 | +0.7% | €200.71 | €200.93 | €200.35 | 104 | |
| €199.45 | +0.967 | +0.5% | €199.45 | €199.45 | €199.45 | 34 | |
| €198.48 | -1.734 | -0.9% | €198.48 | €198.48 | €198.48 | 0 | |
| €200.21 | +2.318 | +1.2% | €200.21 | €200.21 | €200.21 | 0 | |
| €197.90 | -7.538 | -3.7% | €197.90 | €197.90 | €197.90 | 0 | |
| €205.43 | +20.63 | +11.2% | €199.56 | €205.50 | €199.55 | 10 | |
| €184.81 | -7.96 | -4.1% | €184.81 | €184.81 | €184.81 | 0 | |
| €192.77 | -6.344 | -3.2% | €192.77 | €192.77 | €192.77 | 0 | |
| €199.11 | +3.19 | +1.6% | €189.85 | €199.25 | €189.22 | 10 | |
| €195.92 | +0.40 | +0.2% | €191.96 | €198.97 | €189.44 | 0 | |
| €195.52 | +11.46 | +6.2% | €191.70 | €196.10 | €191.06 | 0 | |
| €184.06 | -1.395 | -0.8% | €184.06 | €184.06 | €184.06 | 0 | |
| €185.46 | -0.724 | -0.4% | €185.46 | €185.46 | €185.46 | 0 | |
| €186.18 | -8.132 | -4.2% | €186.18 | €186.18 | €186.18 | 0 | |
| €194.31 | +15.76 | +8.8% | €183.63 | €194.53 | €181.21 | 0 | |
| €178.55 | +0.378 | +0.2% | €178.55 | €178.55 | €178.55 | 0 | |
| €178.17 | -0.168 | -0.1% | €178.17 | €178.17 | €178.17 | 2 | |
| €178.34 | +0.092 | +0.1% | €178.34 | €178.34 | €178.34 | 0 | |
| €178.25 | -10.03 | -5.3% | €178.25 | €178.25 | €178.25 | 0 | |
| €188.27 | +3.617 | +2.0% | €181.64 | €188.95 | €181.03 | 176 | |
| €184.66 | +6.479 | +3.6% | €178.05 | €185.54 | €177.48 | 0 | |
| €178.18 | +2.33 | +1.3% | €178.18 | €178.18 | €178.18 | 0 | |
| €175.85 | +0.202 | +0.1% | €175.85 | €175.85 | €175.85 | 0 | |
| €175.65 | -9.094 | -4.9% | €175.65 | €175.65 | €175.65 | 0 | |
| €184.74 | +3.789 | +2.1% | €174.98 | €186.04 | €172.66 | 0 | |
| €180.95 | -3.53 | -1.9% | €175.99 | €182.72 | €174.40 | 0 | |
| €184.48 | +2.03 | +1.1% | €174.97 | €184.56 | €174.38 | 0 | |
| €182.45 | +1.733 | +1.0% | €174.29 | €183.24 | €173.14 | 0 | |
| €180.72 | +3.166 | +1.8% | €172.31 | €180.86 | €171.13 | 0 | |
| €177.55 | +0.199 | +0.1% | €172.28 | €179.57 | €172.15 | 0 | |
| €177.35 | -2.936 | -1.6% | €174.20 | €178.99 | €174.00 | 0 | |
| €180.29 | -0.04 | 0.0% | €176.59 | €181.27 | €175.80 | 0 | |
| €180.33 | -3.635 | -2.0% | €174.20 | €181.53 | €174.17 | 0 | |
| €183.96 | +2.115 | +1.2% | €175.03 | €186.13 | €174.22 | 0 | |
| €181.85 | +0.103 | +0.1% | €173.77 | €182.03 | €172.01 | 0 | |
| €181.75 | -0.479 | -0.3% | €176.32 | €182.91 | €176.28 | 0 | |
| €182.22 | -2.58 | -1.4% | €177.41 | €182.62 | €176.85 | 20 | |
| €184.80 | -2.044 | -1.1% | €182.36 | €185.13 | €181.52 | 0 | |
| €186.85 | -2.123 | -1.1% | €184.22 | €187.63 | €182.86 | 0 | |
| €188.97 | -3.605 | -1.9% | €186.09 | €189.90 | €185.32 | 0 | |
| €192.58 | +1.411 | +0.7% | €187.33 | €193.34 | €187.21 | 0 | |
| €191.17 | -11.55 | -5.7% | €191.17 | €191.17 | €191.17 | 0 | |
| €202.71 | +10.51 | +5.5% | €190.77 | €202.96 | €190.62 | 40 | |
| €192.21 | -5.526 | -2.8% | €192.21 | €192.21 | €192.21 | 0 | |
| €197.73 | -1.812 | -0.9% | €193.81 | €198.20 | €193.45 | 0 | |
| €199.54 | -1.234 | -0.6% | €191.81 | €200.41 | €190.24 | 0 | |
| €200.78 | +7.905 | +4.1% | €195.57 | €201.06 | €195.43 | 0 | |
| €192.87 | -2.137 | -1.1% | €192.87 | €192.87 | €192.87 | 0 | |
| €195.01 | +1.121 | +0.6% | €195.01 | €195.01 | €195.01 | 0 | |
| €193.89 | -8.956 | -4.4% | €193.89 | €193.89 | €193.89 | 0 | |
| €202.84 | +8.279 | +4.3% | €194.70 | €203.84 | €192.16 | 66 | |
| €194.57 | +3.769 | +2.0% | €194.57 | €194.57 | €194.57 | 0 |
- Ticker
- Frankfurt:2TG
- Asset type
- Stock
- Sector
- Health care
- Industry
- Medical devices & supplies
- Exchange
- Frankfurt
- Currency
- EUR
What changed lately
Latest news release · Nov 4, 2026
STERIS Announces Financial Results for Fiscal 2027 Second Quarter
Latest earnings call · Aug 6, 2026
STERIS plc (Ireland) (NYSE:STE) Q1 2027 Earnings Call
Replay and transcript
Latest deck · August 2026
STERIS — Investor Presentation (August 2026)
Investor deck · 21 slides
Latest news
STERIS Announces Financial Results for Fiscal 2027 Second Quarter
Nov 4, 2026
Closed €211.56 (+8.1%) on Nov 5, 2026
STERIS Announces Dividend of $0.69 per share
Oct 28, 2026
Closed €199.45 (+0.5%) on Oct 29, 2026
STERIS to Host a Conference Call for Fiscal 2027 Second Quarter on November 5, 2026
Oct 20, 2026
Closed €192.77 (-3.2%) on Oct 21, 2026
Xodus Medical Announces Agreement to Be Acquired by STERIS (NYSE: STE)
Oct 12, 2026
Closed €186.18 (-4.2%) on Oct 13, 2026
STERIS Expands Healthcare Consumables Offering with Definitive Agreement to Acquire Xodus Medical, a Specialty Surgical Products Business Focused on Patient and OR Staff Safety
Oct 12, 2026
Closed €194.31 (+8.8%) on Oct 12, 2026
STERIS to Present at the Morgan Stanley Healthcare Conference
Sep 1, 2026
Closed €202.71 (+5.5%) on Sep 2, 2026
STERIS Announces Financial Results for Fiscal 2027 First Quarter
Aug 5, 2026
Closed €192.02 (-0.2%) on Aug 6, 2026
STERIS To Invest $600 Million to Build a Formulated Chemistries Manufacturing and Distribution Center of Excellence in North Carolina
Aug 5, 2026
Closed €192.37 (-4.1%) on Aug 5, 2026
STERIS Raises Dividend to $0.69 per share
Jul 30, 2026
Closed €196.59 (-0.4%) on Jul 31, 2026
STERIS to Host a Conference Call for Fiscal 2027 First Quarter on August 6, 2026
Jul 27, 2026
Closed €181.92 (+0.8%) on Jul 28, 2026
STERIS plc (Ireland) on 6ix
- Sector
- Health care
- Industry
- Medical devices & supplies
- News releases
- 17 in the last 12 months · 27 in all · newest Nov 4, 2026 · oldest 2025
- Calls
- 29 calls with a replay · 29 with a transcript · latest Aug 6, 2026
- Decks
- 14 decks · latest August 2026
Where STERIS plc (Ireland) is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NYSE:STE · Home listing | NYSE | United States | USD |
| LS Exchange:A2PGLV | LS Exchange | Germany | EUR |
| gettex:2TG | gettex | Germany | EUR |
| BX Swiss:STE | BX Swiss | Switzerland | CHF |
| Lang & Schwarz:A2PGLV | Lang & Schwarz | Germany | EUR |
| BMV:STEN | BMV | Mexico | MXN |
| Tradegate:2TG | Tradegate | Germany | EUR |
| BOATS:STE | BOATS | United States | USD |
| Frankfurt:2TG · This page | Frankfurt | Germany | EUR |
| LSE:0XI8 | LSE | United Kingdom | EUR |
| B3:S1TE34 | B3 | Brazil | BRL |
| Dusseldorf:2TG | Dusseldorf | Germany | EUR |
| Munich:2TG | Munich | Germany | EUR |
| BIVA:STEN | BIVA | Mexico | MXN |
| Hamburg:2TG | Hamburg | Germany | EUR |
| Hanover:2TG | Hanover | Germany | EUR |
| Stuttgart:2TG | Stuttgart | Germany | EUR |
Valuation
P/E 30.2× against a median of 29.3×: 7th lowest of 11 Medical devices & supplies companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- $26.30B USD
- P/E
- 30.2×
- EV/sales
- 4.3×
- EV/EBITDA
- 15.8×
- Price/book
- 3.4×
- Gross margin
- 44.6%
- Operating margin
- 19.0%
- Net margin
- 13.4%
- Debt to equity
- 0.3×
- Beta vs S&P 500
- 0.40
Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| STERIS plc (Ireland) · NYSE:STE | US$24.94B | US$26.30B | 30.2× | 4.3× | 15.8× | 3.4× | 13.4% | 0.3× | 0.40 |
| GE HealthCare Technologies Inc. · NASDAQ:GEHC | US$36.46B | US$43.61B | 16.9× | 2.0× | 13.7× | 3.1× | 10.0% | 0.9× | 0.65 |
| Alcon AG · SIX:ALC | US$35.86B | US$38.74B | 54.0× | 3.5× | 16.1× | 1.6× | 6.1% | 0.2× | n/a |
| Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Class A · SZSE:300760 | US$33.36B | US$30.38B | 28.7× | 5.9× | n/a | 5.4× | 22.4% | 0.0× | n/a |
| ResMed Inc. · NYSE:RMD | US$33.14B | US$32.54B | 20.8× | 5.7× | 15.6× | 5.6× | 27.8% | 0.1× | 0.48 |
| DexCom, Inc. · NASDAQ:DXCM | US$29.58B | US$28.62B | 29.9× | 5.6× | n/a | 11.7× | 19.4% | 0.0× | 0.71 |
| Koninklijke Philips N.V. · EURONEXT:PHIA | US$28.31B | US$34.23B | 27.0× | 1.8× | 10.0× | 2.2× | 5.4% | 0.7× | n/a |
| Sonova Holding AG · SIX:SOON | US$20.69B | US$21.87B | 40.4× | 5.1× | 19.6× | 6.7× | 11.9% | 0.7× | n/a |
| Straumann Holding AG · SIX:STMN | US$20.27B | US$20.39B | 47.8× | 6.6× | 24.6× | 7.5× | 13.7% | 0.2× | n/a |
| Zimmer Biomet Holdings, Inc. · NYSE:ZBH | US$19.13B | US$26.24B | 24.9× | 3.1× | 11.6× | 1.5× | 8.9% | 0.6× | 0.40 |
| Coloplast A/S Class B · OMXCOP:COLO_B | US$15.08B | US$18.16B | 33.4× | 4.3× | 10.5× | 7.2× | 10.6% | 1.5× | n/a |
| Median of the others | US$28.95B | US$29.50B | 29.3× | 4.7× | 14.6× | 5.5× | 11.3% | 0.4× | 0.56 |
Forecasts
4 strong buy · 1 buy · 3 hold · Analysts' consensus from EODHD, read Nov 19, 2026. Not 6ix's view and not investment advice.
- Price target
- 281.14 USD · Analysts' mean
- EPS, year to Mar 2027
- 11.44 · 8 analysts
- Revenue, year to Mar 2027
- 6.39B · 8 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| Julie Winter | Vice President, Investor Relations and Corporate Communications |
Board
| Director | Role |
|---|---|
| Pierre Boulud | Director |
Events
Calls
| Call | When | Status |
|---|---|---|
| STERIS plc (Ireland) (NYSE:STE) Q1 2027 Earnings Call | Thu, Aug 06, 2026 · 9:00 AM ET | Replay |
| STERIS plc (Ireland) (NYSE:STE) Q4 2026 Earnings Call | Tue, May 12, 2026 · 9:00 AM ET | Replay |
| STERIS plc (Ireland) (NYSE:STE) Q3 2026 Earnings Call | Thu, Feb 05, 2026 · 9:00 AM ET | Replay |
| STERIS plc (Ireland) (NYSE:STE) Q2 2026 Earnings Call | Thu, Nov 06, 2025 · 9:00 AM ET | Replay |
| STERIS plc (Ireland) (NYSE:STE) Q1 2026 Earnings Call | Thu, Aug 07, 2025 · 9:00 AM ET | Replay |
| STERIS plc (Ireland) (NYSE:STE) Q4 2025 Earnings Call | Thu, May 15, 2025 · 12:00 PM ET | Replay |
| STERIS plc (Ireland) (NYSE:STE) Q3 2025 Earnings Call | Thu, Feb 06, 2025 · 9:00 AM ET | Replay |
| STERIS plc (Ireland) (NYSE:STE) Q2 2025 Earnings Call | Thu, Nov 07, 2024 · 9:00 AM ET | Replay |
| STERIS plc (Ireland) (NYSE:STE) Q1 2025 Earnings Call | Wed, Aug 07, 2024 · 9:00 AM ET | Replay |
| STERIS plc (Ireland) (NYSE:STE) Q4 2024 Earnings Call | Thu, May 09, 2024 · 9:00 AM ET | Replay |
All 29 calls
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q2 2027 | Nov 4, 2026 · After close | +2.5% |
| Q1 2027 | Aug 5, 2026 · After close | −0.4% |
| Q4 2026 | May 11, 2026 · After close | +4.5% |
| Q3 2026 | Feb 4, 2026 · After close | −7.7% |
| Q2 2026 | Nov 5, 2025 · After close | +6.9% |
| Q1 2026 | Aug 6, 2025 · After close | +6.8% |
| Q4 2025 | May 14, 2025 · After close | +8.5% |
| Q3 2025 | Feb 5, 2025 · After close | +2.1% |
| Q2 2025 | Nov 6, 2024 · After close | −5.3% |
| Q1 2025 | Aug 6, 2024 · After close | −2.4% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q4 2024 | May 8, 2024 · After close | +7.6% |
| Q3 2024 | Feb 7, 2024 · After close | −2.5% |
| Q2 2024 | Nov 7, 2023 · After close | −5.5% |
| Q1 2024 | Aug 1, 2023 · After close | +1.7% |
| Q4 2023 | May 10, 2023 · After close | +9.8% |
| Q3 2023 | Feb 8, 2023 · After close | −10.9% |
| Q2 2023 | Nov 9, 2022 · After close | +5.2% |
| Q1 2023 | Aug 2, 2022 · After close | −9.6% |
| Q4 2022 | May 11, 2022 · After close | +2.7% |
| Q3 2022 | Feb 8, 2022 · After close | +2.9% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| STERIS — Investor Presentation (August 2026) | Investor deck | 21 slides | August 2026 |
| STERIS — Merger or Acquisition (January 2021) | Merger or acquisition | 16 slides | Jan 12, 2021 |
| Steris — Merger or Acquisition (October 2014) | Merger or acquisition | 15 slides | Oct 14, 2014 |
| Steris — Investor Presentation (November 2009) | Investor deck | 42 slides | November 2009 |
| STERIS — Investor Day (November 2005) | Investor day | 94 slides | Nov 15, 2005 |
| STERIS — SG Cowen Healthcare Conference 2005 | Conference | 15 slides | Mar 16, 2005 |
| STERIS — UBS Global Life Sciences Conference 2004 | Conference | 31 slides | Sep 28, 2004 |
| STERIS — Thomas Weisel Partners Healthcare Tailwinds 2004 | Conference | 7 slides | Sep 8, 2004 |
| STERIS — GARP Investors Conference 2004 | Conference | 27 slides | Jun 16, 2004 |
| STERIS — SG Cowen Health Care Conference 2004 | Conference | 28 slides | Mar 10, 2004 |
All 14 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| STERIS — US Bancorp Piper Jaffray Health Care Conference 2004 | Conference | 28 slides | Jan 28, 2004 |
| Steris — JPMorgan Healthcare Conference 2004 | Conference | 25 slides | Jan 12, 2004 |
| STERIS — UBS Global Life Sciences Conference 2003 | Conference | 35 slides | Sep 24, 2003 |
| STERIS — Investor Day (September 2003) | Investor day | 112 slides | Sep 4, 2003 |
Financials
Annual, in USD
Income statement
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5.94B | 5.46B | 5.14B | 4.54B | 4.22B | 3.11B | 3.03B | 2.78B | 2.62B | 2.61B |
| Cost of revenue | 3.31B | 3.06B | 2.92B | 2.56B | 2.34B | 1.76B | 1.71B | 1.61B | 1.53B | 1.59B |
| Gross profit | 2.63B | 2.40B | 2.22B | 1.98B | 1.88B | 1.34B | 1.32B | 1.17B | 1.09B | 1.03B |
| Research and development | 112.9M | 107.6M | 103.7M | 98.5M | 86.7M | 66.3M | 65.5M | 63.0M | 60.8M | 59.4M |
| Selling, general and administrative | 1.41B | 1.33B | 1.25B | 1.09B | 1.32B | 731.3M | 716.7M | 669.9M | 632.0M | 682.0M |
| Operating income | 1.10B | 866.6M | 836.1M | 791.1M | 477.8M | 548.4M | 537.0M | 411.0M | 399.9M | 226.2M |
| Depreciation and amortization | 486.5M | 476.2M | 565.2M | 552.9M | 553.1M | 219.2M | 197.2M | 225.9M | 178.3M | 188.1M |
| EBITDA | 1.59B | 1.34B | 1.40B | 1.34B | 1.03B | 767.6M | 734.3M | 636.9M | 578.2M | 414.3M |
| Interest expense | 60.7M | 86.3M | 144.4M | 108.0M | 89.5M | 37.2M | 40.3M | 45.0M | 50.6M | 44.5M |
| Income before tax | 1.05B | 796.2M | 702.8M | 680.3M | 366.8M | 517.5M | 498.8M | 369.0M | 355.0M | 184.6M |
| Income tax | 262.2M | 184.7M | 149.5M | 124.1M | 82.3M | 120.7M | 90.9M | 64.3M | 63.4M | 74.0M |
| Net income | 782.3M | 614.6M | 378.2M | 107.0M | 243.9M | 397.4M | 407.7M | 303.7M | 290.9M | 110.0M |
| Earnings per share, basic | 7.97 | 6.24 | 3.83 | 1.07 | 2.50 | 4.66 | 4.81 | 3.59 | 3.42 | 1.29 |
| Earnings per share, diluted | 7.93 | 6.20 | 3.81 | 1.07 | 2.48 | 4.63 | 4.76 | 3.55 | 3.39 | 1.28 |
Balance sheet
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 439.6M | 171.7M | 207.0M | 208.4M | 348.3M | 220.5M | 319.6M | 220.6M | 201.5M | 282.9M |
| Short-term investments | 0 | 0 | ||||||||
| Receivables | 1.09B | 1.04B | 1.01B | 865.0M | 799.0M | 609.4M | 586.5M | 564.8M | 528.1M | 483.5M |
| Inventory | 631.8M | 581.3M | 674.5M | 604.4M | 575.0M | 315.1M | 263.5M | 208.2M | 205.7M | 197.8M |
| Current assets | 2.39B | 2.00B | 2.87B | 2.01B | 1.88B | 1.21B | 1.22B | 1.05B | 989.7M | 1.02B |
| Property, plant and equipment | 2.16B | 1.96B | 1.77B | 1.63B | 1.55B | 1.24B | 1.11B | 1.03B | 1.01B | 915.9M |
| Goodwill | 4.19B | 4.10B | 4.07B | 3.88B | 3.94B | 3.03B | 2.36B | 2.32B | 2.43B | 2.23B |
| Total assets | 10.7B | 10.1B | 11.1B | 10.8B | 11.4B | 6.57B | 5.44B | 5.07B | 5.20B | 4.92B |
| Accounts payable | 338.8M | 280.8M | 251.7M | 264.2M | 225.7M | 156.9M | 149.3M | 152.9M | 135.9M | 133.5M |
| Current liabilities | 1.15B | 1.02B | 931.1M | 861.8M | 922.2M | 577.9M | 503.6M | 465.2M | 398.5M | 381.6M |
| Long-term debt | 1.81B | 1.92B | 3.12B | 3.02B | 2.95B | 1.65B | 1.15B | 1.18B | 1.32B | 1.48B |
| Total debt | 1.93B | 2.04B | 3.21B | 3.08B | 3.09B | 1.65B | 1.15B | 1.18B | 1.32B | 1.55B |
| Total liabilities | 3.54B | 3.53B | 4.75B | 4.73B | 4.88B | 2.68B | 2.02B | 1.89B | 1.98B | 2.11B |
| Shareholders' equity | 7.18B | 6.60B | 6.30B | 6.08B | 6.53B | 3.88B | 3.41B | 3.18B | 3.21B | 2.81B |
| Shares outstanding | 97.8M | 98.3M | 98.9M | 98.6M | 100.1M | 85.4M | 84.9M | 84.5M | 84.7M | 84.9M |
Cash flow
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 1.34B | 1.15B | 973.3M | 756.9M | 684.8M | 689.6M | 590.6M | 539.5M | 457.6M | 424.1M |
| Capital spending | -369.0M | -370.1M | -360.3M | -362.0M | -287.6M | -239.3M | -214.5M | -189.7M | -165.5M | -172.9M |
| Free cash flow | 972.4M | 778.0M | 613.0M | 395.0M | 397.2M | 450.4M | 376.0M | 349.8M | 292.2M | 251.2M |
| Cash from investing | -512.5M | 388.8M | -887.4M | -383.3M | -666.6M | -1.15B | -319.7M | -213.2M | -203.8M | -104.3M |
| Cash from financing | -568.2M | -1.57B | -85.2M | -498.7M | 115.8M | 345.6M | -163.1M | -294.8M | -356.2M | -267.1M |
| Dividends paid | -241.8M | -219.9M | -200.6M | -183.5M | -163.2M | -133.8M | -123.0M | -112.5M | -102.9M | -93.2M |
| Share buybacks | -235.5M | -211.3M | -11.8M | -308.6M | -55.8M | -14.6M | -51.2M | -81.5M | -65.5M | -97.5M |
| Change in cash | 267.9M | -35.3M | -1.30M | -140.0M | 127.8M | -99.0M | 98.9M | 19.1M | -81.4M | 34.1M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 4 · Change in ownership | Nov 17, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 13, 2026 | Other filings | SEC |
| 4 · Change in ownership | Nov 12, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 12, 2026 | Insider trade | SEC |
| 8-K · Current report | Nov 12, 2026 | Current report | SEC |
| 424B5 · Prospectus | Nov 12, 2026 | Offer document | SEC |
| 144 · Notice of proposed sale | Nov 12, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Nov 10, 2026 | Other filings | SEC |
| FWP · Free writing prospectus | Nov 9, 2026 | Offer document | SEC |
| 424B5 · Prospectus | Nov 6, 2026 | Offer document | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| S-3ASR · Registration statement | Nov 6, 2026 | Offer document | SEC |
| 10-Q · Quarterly report | Nov 5, 2026 | Quarterly report | SEC |
| 8-K · Current report | Nov 4, 2026 | Material contract | SEC |
| 8-K · Current report | Nov 4, 2026 | Results | SEC |
| 8-K · Current report | Oct 13, 2026 | Material contract | SEC |
| 4 · Change in ownership | Oct 5, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 18, 2026 | Other filings | SEC |
| 4 · Change in ownership | Aug 12, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 12, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 12, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 12, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 12, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 12, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 12, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 12, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 12, 2026 | Other filings | SEC |
| 10-Q · Quarterly report | Aug 7, 2026 | Quarterly report | SEC |
| 8-K · Current report | Aug 6, 2026 | Meeting outcome | SEC |
| 8-K/A · Current report, amended | Aug 6, 2026 | Management or board change | SEC |
| 8-K · Current report | Aug 5, 2026 | Results | SEC |
| 4 · Change in ownership | Jul 2, 2026 | Insider trade | SEC |
| 11-K · Annual report of an employee plan | Jun 16, 2026 | Annual report | SEC |
| 4 · Change in ownership | Jun 16, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jun 15, 2026 | Other filings | SEC |
| ARS · Annual report to shareholders | Jun 11, 2026 | Annual report | SEC |
| DEFA14A · Additional proxy material | Jun 11, 2026 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Jun 11, 2026 | Meeting notice | SEC |
| 4 · Change in ownership | Jun 8, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 8, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 8, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 8, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 8, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 8, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 8, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 5, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jun 5, 2026 | Other filings | SEC |
| 4 · Change in ownership | Jun 4, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 4, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 4, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 4, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 4, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 4, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 4, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 4, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 4, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 4, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 4, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jun 4, 2026 | Other filings | SEC |
| 4 · Change in ownership | Jun 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 3, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jun 2, 2026 | Other filings | SEC |
| SD · Specialized disclosure | Jun 1, 2026 | ESG report | SEC |
| 10-K · Annual report | May 29, 2026 | Annual report | SEC |
| 3 · Initial statement of ownership | May 14, 2026 | Insider trade | SEC |
| SCHEDULE 13G · Big-stake notice | May 12, 2026 | Big-stake notice | SEC |
| 8-K · Current report | May 11, 2026 | Results | SEC |
| 8-K · Current report | May 7, 2026 | Management or board change | SEC |
| SCHEDULE 13G · Big-stake notice | Apr 30, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G · Big-stake notice | Apr 29, 2026 | Big-stake notice | SEC |
| 8-K · Current report | Apr 6, 2026 | Management or board change | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Mar 27, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Mar 6, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Mar 5, 2026 | Other filings | SEC |
| 10-Q · Quarterly report | Feb 6, 2026 | Quarterly report | SEC |
| 8-K · Current report | Feb 4, 2026 | Results | SEC |
| 4 · Change in ownership | Jan 6, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jan 6, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 25, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 21, 2025 | Other filings | SEC |
| 4 · Change in ownership | Nov 20, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 18, 2025 | Other filings | SEC |
| 4 · Change in ownership | Nov 13, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 12, 2025 | Other filings | SEC |
| 10-Q · Quarterly report | Nov 6, 2025 | Quarterly report | SEC |
| 8-K · Current report | Nov 5, 2025 | Results | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Nov 4, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Oct 8, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Oct 6, 2025 | Other filings | SEC |
| 4 · Change in ownership | Oct 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Oct 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Oct 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Oct 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Oct 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Oct 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Oct 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 22, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 20, 2025 | Other filings | SEC |
| 4 · Change in ownership | Aug 15, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 12, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 12, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Aug 11, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Aug 11, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Aug 11, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Aug 11, 2025 | Other filings | SEC |
| 10-Q · Quarterly report | Aug 7, 2025 | Quarterly report | SEC |
| 3 · Initial statement of ownership | Aug 6, 2025 | Insider trade | SEC |
| 8-K · Current report | Aug 6, 2025 | Results | SEC |
| DEFA14A · Additional proxy material | Jul 3, 2025 | Meeting notice | SEC |
| 8-K · Current report | Jul 3, 2025 | Management or board change | SEC |
| 11-K · Annual report of an employee plan | Jun 25, 2025 | Annual report | SEC |
| 4 · Change in ownership | Jun 17, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jun 13, 2025 | Other filings | SEC |
| ARS · Annual report to shareholders | Jun 12, 2025 | Annual report | SEC |
| DEFA14A · Additional proxy material | Jun 12, 2025 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Jun 12, 2025 | Meeting notice | SEC |
| 4 · Change in ownership | Jun 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 6, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jun 5, 2025 | Other filings | SEC |
| 4 · Change in ownership | Jun 5, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 5, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 5, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 5, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 5, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 5, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 5, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 5, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 5, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 4, 2025 | Insider trade | SEC |
| SD · Specialized disclosure | May 30, 2025 | ESG report | SEC |
| 10-K · Annual report | May 29, 2025 | Annual report | SEC |
| 4 · Change in ownership | May 22, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | May 20, 2025 | Other filings | SEC |
| 8-K · Current report | May 14, 2025 | Results | SEC |
| 8-K · Current report | Mar 3, 2025 | Current report | SEC |
| 10-Q · Quarterly report | Feb 7, 2025 | Quarterly report | SEC |
| 8-K · Current report | Feb 5, 2025 | Results | SEC |
| 4 · Change in ownership | Nov 27, 2024 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 25, 2024 | Other filings | SEC |
| SC 13G/A · Big-stake notice, amended | Nov 8, 2024 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Nov 7, 2024 | Quarterly report | SEC |
| 8-K · Current report | Nov 6, 2024 | Results | SEC |
| SC 13G/A · Big-stake notice, amended | Oct 21, 2024 | Big-stake notice | SEC |
| 8-K · Current report | Oct 7, 2024 | Material contract | SEC |
| 4 · Change in ownership | Oct 2, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Oct 2, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Oct 2, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Oct 2, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Oct 2, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Oct 2, 2024 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Oct 2, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Sep 17, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Sep 12, 2024 | Insider trade | SEC |
| 144 · Notice of proposed sale | Sep 10, 2024 | Other filings | SEC |
| 4 · Change in ownership | Aug 12, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Aug 12, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Aug 12, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Aug 12, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Aug 12, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Aug 12, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Aug 12, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Aug 12, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Aug 12, 2024 | Insider trade | SEC |
| 10-Q · Quarterly report | Aug 8, 2024 | Quarterly report | SEC |
| 8-K · Current report | Aug 6, 2024 | Results | SEC |
| 8-K · Current report | Aug 1, 2024 | Meeting outcome | SEC |
| 11-K · Annual report of an employee plan | Jun 21, 2024 | Annual report | SEC |
This page holds 200 of 694 filings. Open Filings
Cap table
Built by 6ix from STERIS plc (Ireland)’s releases
- Common shares
- 97,500,110
- Fully diluted
- 97,500,110
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 97,500,110 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 97,500,110 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Jacqueline B Kosecoff Other companies: Alignment Healthcare, Inc. (Director · Since at least Mar 25, 2021); TriNet Group, Inc. (Director · Since at least Jan 15, 2020); GoodRx Holdings, Inc. (Director · Sep 23, 2020 – Dec 31, 2022 · Past); Houlihan Lokey, Inc. (Director · Jun 20, 2016 – May 22, 2025 · Past); Sealed Air Corporation (Director · May 19, 2016 – May 21, 2020 · Past); athenahealth Inc (Director · Mar 1, 2016 – Feb 11, 2019 · Past) | Director · Aug 31, 2015 – Aug 8, 2024 · Past |
| Paul E. Martin Other companies: Owens Corning Inc (Board Member · Since at least Feb 3, 2021); Unisys Corporation New (Director · Since at least Feb 9, 2017); Ping Identity Holding Corp (Director · Jan 1, 2021 – Oct 18, 2022 · Past) | Director · Since at least May 5, 2021 |
| David B Lewis Other companies: H&R Block, Inc. (Director · Nov 1, 2010 – Sep 10, 2020 · Past); Kroger Company (the) (Director · Mar 1, 2010 – Jun 1, 2016 · Past) | Director · Jul 29, 2010 – Jul 21, 2021 · Past |
| Michael J. Tokich Other companies: Teleflex Incorporated (Director · Since at least May 15, 2026); Mettler-Toledo International, Inc. (Director · Since at least Jan 20, 2026) | Sr. Vice Pres., CFO · Since at least Apr 7, 2022 |
| Esther M Alegria Other companies: Avid Bioservices Inc (Director · Dec 14, 2023 – Feb 5, 2025 · Past) | Director · Since at least Aug 8, 2024 |
| John P Wareham Other companies: ResMed Inc. (Director · Aug 8, 2016 – Nov 1, 2019 · Past) | Director · Aug 10, 2016 – Aug 9, 2017 · Past |
| Mohsen M. Sohi Other companies: Baker Hughes Company (Director · Since at least Jan 25, 2023) | Director · Since at least Aug 3, 2022 |
| Cary L Majors | SVP and President, Healthcare · Since at least May 7, 2019 |
| Daniel A Carestio | President and CEO, Director · Since at least Jun 2, 2025 |
| David Allen Johnson | Sr. VP. Surgical Solutions · Jul 26, 2012 – Aug 10, 2015 · Past |
All 22 people
| Person | Seat |
|---|---|
| John Adam Zangerle | Sr. VP, Gen Counsel, and Sec. · Since at least Aug 10, 2015 |
| Julia Madsen | Sr. VP and GM, Life Sciences · Since at least May 31, 2022 |
| Julie Winter | Vice President, Investor Relations and Corporate Communications · Since at least Oct 28, 2026 |
| Kenneth E Kohler | SVP & GM, AST · Since at least Jun 2, 2025 |
| Kim Duncan | Vice President, Investor Relations and Risk Management · Dec 23, 2025 – Nov 5, 2026 · Past |
| Lindsey McGowan | VP, Chf. Comp. & Quality Offc. · Since at least Jan 1, 2026 |
| Loyal W Wilson | Director · Aug 8, 2013 – Jun 4, 2019 · Past |
| Mary Clare Fraser | SVP & Chief HRO · Since at least Jun 3, 2024 |
| Nirav R Shah | Director · Since at least Aug 8, 2025 |
| Pierre Boulud | Director · Since at least May 7, 2026 |
| Renato Tamaro | V.P. & Corporate Treasurer · Since at least Jun 1, 2026 |
| Richard C Breeden | Director · Since at least May 21, 2024 |
Log in to ask 6ix AI your own questions about STERIS plc (Ireland).